| Product Information |
|
| Registration Number |
DR-XY16826
|
| Generic Name |
Lacidipine
|
| Brand Name |
Lacipil
|
| Dosage Strength |
2 mg
|
| Dosage Form |
Film Coated Tablet
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Selective Calcium Channel Blockers with Mainly Vascular Effects (Dihydropyridine derivatives)
|
| Packaging |
Child-Resistant Aluminum Foil Blister Pack x 7's (Box of 28's)
|
| Manufacturer |
Glaxo Wellcome S.A.
|
| Country of Origin |
Spain
|
| Trader |
|
| Importer |
GlaxoSmithKline Philippines, inc.
|
| Distributor |
|
| Application Type |
Automatic Renewal
|
| Issuance Date |
21 July 2023
|
| Expiry Date |
18 August 2028
|